Safety and efficacy of mitapivat in sickle cell disease (RISE UP): results from the phase 2 portion of a global, double-blind, randomised, placebo-controlled trial
Riociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD): a randomised, double-blind, placebo controlled, phase 1–2 trial
Association of biomarkers of endothelial function, coagulation activation and kidney injury with persistent albuminuria in sickle cell anaemia
Kidney failure outcomes in children and young adults with sickle cell disease in the United States Renal Data System
The nephropathy of sickle cell trait and sickle cell disease
Patients with sickle cell disease who develop end‐stage kidney disease continue to experience poor survival — A 19‐year United States Renal Data System study
Longitudinal study of glomerular hyperfiltration in adults with sickle cell anemia: a multicenter pooled analysis
Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trial
Low hemoglobin increases risk for cerebrovascular disease, kidney disease, pulmonary vasculopathy, and mortality in sickle cell disease: A systematic literature review and meta-analysis
Rapid decline in estimated glomerular filtration rate in sickle cell anemia: results of a multicenter pooled analysis
High bias and low precision for estimated versus measured glomerular filtration rate in pediatric sickle cell anemia
Higher Hemoglobin Levels Achieved with Voxelotor Are Associated with Lower Vaso-occlusive Crisis Incidence: 72-Week Analysis from the HOPE Study
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease
American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease
Red blood cells modulate structure and dynamics of venous clot formation in sickle cell disease
A pilot study of the effect of atorvastatin on endothelial function and albuminuria in sickle cell disease
Decreased median survival of adults with sickle cell disease after adjusting for left truncation bias: a pooled analysis
Effect of crizanlizumab on pain crises in subgroups of patients with sickle cell disease: A SUSTAIN study analysis
Prevalence of inherited blood disorders and associations with malaria and anemia in Malawian children
Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease
Albuminuria Is Associated with Endothelial Dysfunction and Elevated Plasma Endothelin-1 in Sickle Cell Anemia
Factors associated with survival in a contemporary adult sickle cell disease cohort
The glomerulopathy of sickle cell disease
IMPROVE trial: A randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studies
A dose‐escalation phase IIa study of 2,2‐dimethylbutyrate (HQK‐1001), an oral fetal globin inducer, in sickle cell disease
A potent oral P‐selectin blocking agent improves microcirculatory blood flow and a marker of endothelial cell injury in patients with sickle cell disease
Refining the value of secretory phospholipase <scp>A</scp><sub>2</sub> as a predictor of acute chest syndrome in sickle cell disease: results of a feasibility study (<scp>PROACTIVE</scp>)
A phase 1/2 trial of HQK‐1001, an oral fetal globin inducer, in sickle cell disease